DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20163850

Medication abortion in missed abortion up to 13 weeks amenorrhoea: a prospective study

Divya R. Prasad, Neelima V. Nair

Abstract


Background: Missed abortion is a type of abortion in which the dead fetus is retained within the uterus. The objective of the study was to find out whether the use of medication abortion is safe and effective in termination of missed abortion up to 13 weeks of pregnancy.

Methods: This study was conducted in a tertiary care center as a prospective study, for a period of 24 months from April 2013 to March 2014. Sample size consisted of 150 cases of missed abortion up to 13 weeks of pregnancy which was confirmed by ultrasound. These patients were given medication abortion and was followed up for complications viz., pain, excessive bleeding, need for surgical evacuation, rupture uterus, infection and coagulopathy.

Results: In the present study, 16 % required surgical evacuation. The common complications were pain (8%), nausea and vomiting (4.7%), low grade fever (3.3%), excessive bleeding (6%). There were no cases of rupture uterus or coagulopathy, or infections.

Conclusions: Medication abortion is a safe and effective method for the termination of missed abortion up to 13 weeks of pregnancy with fewer complications thus reducing the need for surgical methods.


Keywords


Complications, Medication abortion, Missed abortion

Full Text:

PDF

References


Cunningham GF, Norman F. Abortion. Williams Obstetrics 21st Edition. 35:867-868.

Harlap S, Shiono PH. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet. 1980;2:173.

Wagaarachchi PT, Ashok PW, Narvekar N, Smith NC, Templeton A. Medical management of early fetal demise using a combination of Mifepristone and Misoprostol. Hum Reprod. 2001;16(9):1849-53.

Nielsen S, Hahlin M, PtetZr Christensen JJ. Unsuccessful treatment of missed abortion with a combination of antiprogesterone and a prostaglandin E1 analogue. BJOG. 1997;104:1094-96.

Zieman M, Fong S, Benowitz NL. Absorption Kinetics of Misoprostol with Oral or Vaginal Administration. Obstet Gynecol. 1997;90:88-92.

Crenin MD, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol. 1997;89:768-72.

El-Refaey H, Hinshaw K, Henshaw R. Medical management of missed abortion and anembryonic pregnancy. Br Med J. 1992;1399:305.

Hinshaw HKS. Medical management of miscarriage. I N Grudzinkas JG, O'Brien PMS. (eds) Problems in early pregnancy: advances in diagnosis and management. RCOG Press, London; 1997:284-295.

WHO Task Force. WHO task force on post-ovulatory methods of fertility regulation. Termination of pregnancy with reduced doses of Mifepristone. Br Med J. 1993;307:532-7.

de Jonge ETM, Makin JD, Manefeldt E. Randomized clinical trial of medical evacuation and surgical curettage for incomplete miscarriage. Br Med J. 1995;311:662.

Ashok PW, Penney GC, Flett GMM, Templeton A. An effective regimen for early medical abortion: A report of 2000 consecutive cases. Human Reproduction. 1998;13:2962-5.

Chung T, Leung P, Cheung LP. A medical approach to management of spontaneous abortion using misoprostol. Acta Obstet Gynecol Scand. 1997;76:248-51.

Demetroulis C, Saridogan E, Kunde D. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Hum Reprod. 2001;16(2):365-9.

Nguyen TNN, Winikoff B, Clark S. Safety, Efficacy and Acceptability of Mifepristone-Misoprostol Medical Abortion in Vietnam International Family Planning Perspectives. 1999;25(1):10-14.